{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:10:18Z","timestamp":1791227418671,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T00:00:00Z","timestamp":1671580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T00:00:00Z","timestamp":1671580800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pharmacol Toxicol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>The aim of this work was to investigate the association between anticholinergic burden or anticholinergic drug use and xerostomia and\/or xerophtalmia in elderly through a systematic review of the published literature.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A search was carried out in 3 databases (CINAHL, Embase and Pubmed). Studies conducted in people \u226565\u2009years of age, who took anticholinergic medications, and measured the association between the anticholinergic burden or the use of these medications with the prevalence of xerostomia and \/ or xerophthalmia, published up to August 2022, were selected. Studies published in languages other than Spanish and\/or English were excluded.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>One thousand two hundred eleven articles were identified, 10 were selected for this review: six cross-sectional studies, two cohorts, one case-control and one randomized controlled clinical trial. A total of 3535 patients included in the different studies were studied. The most used scales were the Anticholinergic Drug Scale (ADS) and the Anticholinergic Risk Scale (ARS). Four articles studied the relationship between the use of anticholinergic medication and the prevalence of xerostomia and \/ or xerophthalmia, finding a positive relationship with xerostomia in all of them. Another 6 measured the relationship between anticholinergic burden and xerostomia and \/ or xerophthalmia. Four found a positive relationship between anticholinergic burden and xerostomia and\/or xerophthalmia.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our findings suggest a clear relationship between the use of anticholinergic drugs or anticholinergic burden and the presence of xerostomia. This relationship was less conclusive in the case of xerophthalmia.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40360-022-00637-8","type":"journal-article","created":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T02:03:47Z","timestamp":1671588227000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Association between anticholinergic activity and xerostomia and\/ or xerophthalmia in the elderly: systematic review"],"prefix":"10.1186","volume":"23","author":[{"given":"E.","family":"Prado-Mel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Ciudad-Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Rodr\u00edguez-Ramallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3630-7122","authenticated-orcid":false,"given":"S.","family":"S\u00e1nchez-Fidalgo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Santos-Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. M.","family":"Villalba-Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,21]]},"reference":[{"issue":"2","key":"637_CR1","doi-asserted-by":"publisher","first-page":"186\u20138","DOI":"10.12968\/denu.2016.43.2.186","volume":"43","author":"C Bostock","year":"2016","unstructured":"Bostock C, McDonald C. Antimuscarinics in older people: dry mouth and beyond. Dent Update. 2016;43(2):186\u20138\u2013191.","journal-title":"Dent Update"},{"issue":"5","key":"637_CR2","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1093\/ageing\/afu096","volume":"43","author":"C Fox","year":"2014","unstructured":"Fox C, Smith T, Maidment I, Chan WY, Bua N, Myint PK, et al. Effect of medications with anti-cholinergic properties on cognitive function, delirium, physical function and mortality: a systematic review. Age Ageing. 2014;43(5):604\u201315.","journal-title":"Age Ageing"},{"issue":"1","key":"637_CR3","doi-asserted-by":"publisher","first-page":"29","DOI":"10.4321\/S0213-12852009000100004","volume":"25","author":"I Arriola Riestra","year":"2009","unstructured":"Arriola Riestra I, Santos Marino J, Mart\u00ednez Rodr\u00edguez N, Barona Dorado C, Mart\u00ednez Gonz\u00e1lez JM. Consideraciones farmacodin\u00e1micas y farmacocin\u00e9ticas en los tratamientos habituales del paciente gerodontol\u00f3gico. Av Odontoestomatol. 2009 [25(1):29\u201334 http:\/\/scielo.isciii.es\/scielo.php?script=sci_arttext&pid=S0213-12852009000100004&lng=es.","journal-title":"Av Odontoestomatol"},{"issue":"1","key":"637_CR4","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.rpsmen.2015.03.001","volume":"8","author":"J L\u00f3pez-\u00c1lvarez","year":"2015","unstructured":"L\u00f3pez-\u00c1lvarez J, Zea Sevilla MA, Ag\u00fcera Ortiz L, Fern\u00e1ndez Bl\u00e1zquez M\u00c1, Valent\u00ed Soler M. Effect of anticholinergic drugs on cognitive impairment in the elderly. Rev Psiquiatr Salud Ment (Engl Ed). 2015;8(1):35\u201343. https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S2173505015000035?via%3Dihub. https:\/\/doi.org\/10.1016\/j.rpsmen.2015.03.001.","journal-title":"Rev Psiquiatr Salud Ment (Engl Ed)"},{"issue":"2","key":"637_CR5","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/bcp.12617","volume":"80","author":"K Ruxton","year":"2015","unstructured":"Ruxton K, Woodman RJ, Mangoni AA. Drugs with anticholinergic effects and cognitive impairment, falls and all-cause mortality in older adults: a systematic review and meta-analysis. Br J Clin Pharmacol. 2015;80(2):209\u201320.","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"637_CR6","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/jppr.1303","volume":"47","author":"L Kouladjian-O\u2019Donnell","year":"2017","unstructured":"Kouladjian-O\u2019Donnell L, Gnjidic D, Nahas R, Bell J, Hilmer S. Anticholinergic burden: considerations for older adults. J Pharm Pract Res. 2017;47(1):67\u201377.","journal-title":"J Pharm Pract Res"},{"issue":"2","key":"637_CR7","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1093\/arclin\/acu073","volume":"30","author":"CK Block","year":"2015","unstructured":"Block CK, Logue E, Thaler NS, Scarisbrick DM, Mahoney JJ, Scott J, et al. The interaction between medical burden and anticholinergic cognitive burden on neuropsychological function in a geriatric primary care sample. Arch Cli Neuropsychol. 2015;30(2):105\u201313.","journal-title":"Arch Cli Neuropsychol"},{"issue":"7592","key":"637_CR8","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1136\/bmj.39036.433542.68","volume":"334","author":"M Taubert","year":"2007","unstructured":"Taubert M, Davies EM, Back I. Dry mouth. BMJ. 2007;334(7592):534.","journal-title":"BMJ."},{"issue":"3","key":"637_CR9","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/j.1875-595X.2000.tb00554.x","volume":"50","author":"LM Sreebny","year":"2000","unstructured":"Sreebny LM. Saliva in health and disease: an appraisal and update. Int Dent J. 2000;50(3):140\u201361.","journal-title":"Int Dent J"},{"issue":"1","key":"637_CR10","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/jicd.12120","volume":"7","author":"S Anil","year":"2016","unstructured":"Anil S, Vellappally S, Hashem M, Preethanath RS, Patil S, Samaranayake LP. Xerostomia in geriatric patients: a burgeoning global concern. J Investig Clin Dent. 2016;7(1):5\u201312.","journal-title":"J Investig Clin Dent"},{"issue":"10","key":"637_CR11","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s40266-018-0588-5","volume":"35","author":"AG Barbe","year":"2018","unstructured":"Barbe AG. Medication-induced xerostomia and Hyposalivation in the elderly:culprits, complications, and management. Drugs Aging. 2018;35(10):877\u201385.","journal-title":"Drugs Aging"},{"issue":"1","key":"637_CR12","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/ger.12313","volume":"35","author":"JPAR Amaral","year":"2018","unstructured":"Amaral JPAR, Marques DNDS, Thomson WM, Vinagre ARR, da Mata ADSP. Validity and reliability of a Portuguese version of the summated xerostomia inventory 5. Gerodontology. 2018;35(1):33\u20137.","journal-title":"Gerodontology."},{"issue":"4","key":"637_CR13","doi-asserted-by":"publisher","first-page":"335","DOI":"10.2165\/00002512-199303040-00004","volume":"3","author":"M Feinberg","year":"1993","unstructured":"Feinberg M. The problems of anticholinergic adverse effects in older patients. Drugs Aging. 1993;3(4):335\u201348.","journal-title":"Drugs Aging"},{"issue":"2","key":"637_CR14","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1097\/NHH.0000000000000652","volume":"36","author":"PA Rouen","year":"2018","unstructured":"Rouen PA, White ML. Dry eye disease: prevalence, assessment, and management. Home Healthc now. 2018;36(2):74\u201383.","journal-title":"Home Healthc now"},{"issue":"9","key":"637_CR15","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1016\/j.jamda.2019.02.007","volume":"20","author":"UL Aalto","year":"2019","unstructured":"Aalto UL, Finne-Soveri H, Kautiainen H, Roitto HM, \u00d6hman H, Pitk\u00e4l\u00e4 KH. Use of anticholinergic drugs according to various criteria and their association with psychological well-being and mortality in long-term care facilities. J Am Med Dir Assoc. 2019;20(9):1156\u201362.","journal-title":"J Am Med Dir Assoc"},{"key":"637_CR16","doi-asserted-by":"publisher","unstructured":"Algra Y, Haverkort E, Kok W, Etten-Jamaludin FV, Schoot LV, Hollaar V, Naumann E, Schueren MV, Jerkovic-Cosic, K. The association between malnutrition and Oral health in older people: a systematic review. Nutrients [Internet] 202113(10): 3584. Available in: https:\/\/www.mdpi.com\/2072-6643\/13\/10\/3584 DOI:https:\/\/doi.org\/10.3390\/nu13103584.","DOI":"10.3390\/nu13103584"},{"issue":"12","key":"637_CR17","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1007\/s00228-019-02744-8","volume":"75","author":"L Andre","year":"2019","unstructured":"Andre L, Gallini A, Montastruc F, Montastruc JL, Piau A, Lapeyre-Mestre M, et al. Association between anticholinergic (atropinic) drug exposure and cognitive function in longitudinal studies among individuals over 50 years old: a systematic review. Eur Clin Pharmacol. 2019;75(12):1631\u201344.","journal-title":"Eur Clin Pharmacol"},{"issue":"12","key":"637_CR18","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1007\/s40266-020-00806-6","volume":"37","author":"J Reinold","year":"2020","unstructured":"Reinold J, Sch\u00e4fer W, Christianson L, Barone-Adesi F, Riedel O, Pisa FE. Anticholinergic burden and fractures: a systematic review with methodological appraisal. Drugs Aging. 2020;37(12):885\u201397.","journal-title":"Drugs Aging"},{"issue":"6","key":"637_CR19","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1093\/ageing\/afaa090","volume":"49","author":"NT Pieper","year":"2020","unstructured":"Pieper NT, Grossi CM, Chan WY, Loke YK, Savva GM, Haroulis C, et al. Anticholinergic drugs and incident dementia, mild cognitive impairment and cognitive decline: a meta-analysis. Age Ageing. 2020;49(6):939\u201347.","journal-title":"Age Ageing"},{"key":"637_CR20","unstructured":"Systematic reviews: CRD\u2019s guidance for undertaking reviews in health care [internet]. 1\u00aa ed. York: Centre for Reviews and Dissemination; 2009 [Cited 2021 Nov 08]. Available from: https:\/\/www.york.ac.uk\/media\/crd\/Systematic_Reviews.pdf."},{"issue":"7","key":"637_CR21","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"21","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;21(7):e1000097.","journal-title":"PLoS Med"},{"key":"637_CR22","volume-title":"JBI Reviewer's Manual [Internet]. The JBI 2017","author":"S Moola","year":"2021","unstructured":"Moola S, Munn Z, Tufanaru C, Aromataris E, Sears K, Sfetcu R, et al. Chapter 7: Systematic reviews of etiology and risk. In: Aromataris E, Munn Z, editors. JBI Reviewer's Manual [Internet]. The JBI 2017; 2021. https:\/\/jbi-global-wiki.refined.site\/space\/MANUAL."},{"key":"637_CR23","unstructured":"Wells G.A, Shea B, O'Connel D. et al. The Ottawa Hospital Research Institute [Internet]. The Newcastle-Ottawa scale (NOS) for assessing the quailty of non-randomised studies in meta-analyses [Cited 2021 Nov 23]. Avalaible from: http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp."},{"key":"637_CR24","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JPT Higgins","year":"2011","unstructured":"Higgins JPT, Altman DG, G\u00f8tzsche PC, J\u00fcni P, Moher D, Oxman AD, et al. The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomized trials. BMJ [Internet]. 2011;343:d5928. https:\/\/www.bmj.com\/content\/343\/bmj.d5928. https:\/\/doi.org\/10.1136\/bmj.d5928.","journal-title":"BMJ [Internet]"},{"issue":"2","key":"637_CR25","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/jcpt.12772","volume":"44","author":"NM Inkeri","year":"2019","unstructured":"Inkeri NM, Karjalainen M, Haanp\u00e4\u00e4 M, Kautiainen H, Saltevo J, M\u00e4ntyselk\u00e4 P, et al. Anticholinergic drug use and its association with self-reported symptoms among older persons with and without diabetes. J Clin Pharm Ther. 2019;44(2):229\u201335.","journal-title":"J Clin Pharm Ther"},{"issue":"1","key":"637_CR26","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/ger.12304","volume":"35","author":"A Tiisanoja","year":"2018","unstructured":"Tiisanoja A, Syrj\u00e4l\u00e4 AM, Komulainen K, Lampela P, Hartikainen S, Taipale H, et al. Anticholinergic burden and dry mouth among Finnish, community-dwelling older adults. Gerodontology. 2018;35(1):3\u201310.","journal-title":"Gerodontology."},{"issue":"957","key":"637_CR27","first-page":"219","volume":"106","author":"WM Thomson","year":"1993","unstructured":"Thomson WM, Brown RH, Williams SM. Medication and perception of dry mouth in a population of institutionalised elderly people. N Z Med J. 1993;106(957):219\u201321.","journal-title":"N Z Med J"},{"issue":"4","key":"637_CR28","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1177\/089198878800100405","volume":"1","author":"IR Katz","year":"1988","unstructured":"Katz IR, Stoff D, Muhly C, Bari M. Identifying persistent adverse effects of anticholinergic drugs in the elderly. J Geriatr Psychiatry Neurol. 1988;1(4):212\u20137.","journal-title":"J Geriatr Psychiatry Neurol"},{"issue":"6","key":"637_CR29","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s12603-012-0007-2","volume":"16","author":"A Desoutter","year":"2012","unstructured":"Desoutter A, Soudain-Pineau M, Munsch F, Mauprivez C, Dufour T, Coeuriot JL. Xerostomia and medication: a cross-sectional study in long-term geriatric wards. J Nutr Health Aging. 2012;16(6):575\u20139.","journal-title":"J Nutr Health Aging"},{"issue":"3","key":"637_CR30","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1111\/j.1365-2125.2012.04411.x","volume":"75","author":"H Kersten","year":"2013","unstructured":"Kersten H, Molden E, Willumsen T, Engedal K, Bruun WT. Higher anticholinergic drug scale (ADS) scores are associated with peripheral but not cognitive markers of cholinergic blockade. Cross sectional data from 21 Norwegian nursing homes. Br J Clin Pharmacol. 2013;75(3):842\u20139.","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"637_CR31","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.amjopharm.2006.03.008","volume":"4","author":"J Ness","year":"2006","unstructured":"Ness J, Hoth A, Barnett MJ, Shorr RI, Kaboli PJ. Anticholinergic medications in community-dwelling older veterans: prevalence of anticholinergic symptoms, symptom burden, and adverse drug events. Am J Geriatr Pharmacother. 2006;4(1):42\u201351.","journal-title":"Am J Geriatr Pharmacother"},{"issue":"5","key":"637_CR32","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1001\/archinternmed.2007.106","volume":"168","author":"JL Rudolph","year":"2008","unstructured":"Rudolph JL, Salow MJ, Angelini MC, McGlinchey RE. The anticholinergic risk scale and anticholinergic adverse effects in older persons. Arch Intern Med. 2008;168(5):508\u201313.","journal-title":"Arch Intern Med"},{"issue":"1","key":"637_CR33","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1007\/s11096-020-01117-x","volume":"43","author":"M Lavrador","year":"2021","unstructured":"Lavrador M, Cabral AC, Figueiredo IV, Ver\u00edssimo MT, Castel-Branco MM, Fernandez-Llimos F. Size of the associations between anticholinergic burden tool scores and adverse outcomes in older patients. Int J Clin Pharm. 2021;43(1):128\u201336.","journal-title":"Int J Clin Pharm"},{"issue":"3","key":"637_CR34","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1093\/gerona\/gls176","volume":"68","author":"H Kersten","year":"2013","unstructured":"Kersten H, Molden E, Tolo IK, Skovlund E, Engedal K, Wyller TB. Cognitive effects of reducing anticholinergic drug burden in a frail elderly population: a randomized controlled trial. J Gerontol A Biol Sci Med Sci. 2013;68(3):271\u20138.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"8","key":"637_CR35","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1001\/archinte.167.8.781","volume":"167","author":"SN Hilmer","year":"2007","unstructured":"Hilmer SN, Mager DE, Simonsick EM, Cao Y, Ling SM, Windham BG, et al. A drug burden index to define the functional burden of medications in older people. Arch Intern Med. 2007;167(8):781\u20137.","journal-title":"Arch Intern Med"},{"issue":"3","key":"637_CR36","doi-asserted-by":"publisher","first-page":"311","DOI":"10.2217\/1745509X.4.3.311","volume":"4","author":"M Boustani","year":"2008","unstructured":"Boustani M, Campbell N, Munger S, Maidment I, Fox C. Impact of anticholinergics on the aging brain: a review and practical application. Aging Health. 2008;4(3):311\u201320.","journal-title":"Aging Health"},{"key":"637_CR37","doi-asserted-by":"publisher","first-page":"45","DOI":"10.2147\/TCRM.S76282","volume":"11","author":"A Villa","year":"2014","unstructured":"Villa A, Connell CL, Abati S. Diagnosis and management of xerostomia and hyposalivation. Ther Clin Risk Manag. 2014;11:45\u201351.","journal-title":"Ther Clin Risk Manag"},{"issue":"1","key":"637_CR38","first-page":"12","volume":"16","author":"WM Thomson","year":"1999","unstructured":"Thomson WM, Chalmers JM, Spencer AJ, Williams SM. The xerostomia inventory: a multi-item approach to measuring dry mouth. Community Dent Health. 1999;16(1):12\u20137.","journal-title":"Community Dent Health"},{"issue":"3","key":"637_CR39","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.rdc.2018.03.002","volume":"44","author":"AN Baer","year":"2018","unstructured":"Baer AN, Walitt B. Update on Sj\u00f6gren syndrome and other causes of sicca in older adults. Rheum Dis Clin N Am. 2018;44(3):419\u201336.","journal-title":"Rheum Dis Clin N Am"},{"issue":"12","key":"637_CR40","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1177\/0091270006292126","volume":"46","author":"RM Carnahan","year":"2006","unstructured":"Carnahan RM, Lund BC, Perry PJ, Pollock BG, Culp KR. The anticholinergic drug scale as a measure of drug-related anticholinergic burden: associations with serum anticholinergic activity. J Clin Pharmacol. 2006;46(12):1481\u20136.","journal-title":"J Clin Pharmacol"},{"key":"637_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.archger.2015.10.002","volume":"62","author":"AM Villalba-Moreno","year":"2016","unstructured":"Villalba-Moreno AM, Alfaro-Lara ER, Perez-Guerrero MC, Nieto-Martin MD, Santos-Ramos B. Systematic review on the use of anticholinergic scales in poly pathological patients. Arch Gerontol Geriatr. 2016;62:1\u20138.","journal-title":"Arch Gerontol Geriatr"}],"container-title":["BMC Pharmacology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-022-00637-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40360-022-00637-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-022-00637-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T02:05:23Z","timestamp":1671588323000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpharmacoltoxicol.biomedcentral.com\/articles\/10.1186\/s40360-022-00637-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,21]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["637"],"URL":"https:\/\/doi.org\/10.1186\/s40360-022-00637-8","relation":{},"ISSN":["2050-6511"],"issn-type":[{"value":"2050-6511","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,21]]},"assertion":[{"value":"15 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"PME, CGP, RRH, SFS, SRB and VMAM report no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest\/competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"94"}}